IMPROVED SURVIVAL IN PATIENTS >= 60 WITH FIRST RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA TREATED WITH VOSAROXIN PLUS CYTARABINE VS PLACEBO PLUS CYTARABINE: RESULTS FROM THE PHASE 3 VALOR STUDY

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Ravandi, F; Ritchie, EK; Sayar, H; Lancet, JE; Craig, MD; Vey, N; Strickland, SA; Schiller, GJ; Jabbour, E; Erba, HP; Pigneux, A; Horst, HA; Recher, C; Klimek, VM; Cortes, J; Roboz, GJ; Craig, AR; Fox, JA; Ward, R; Smith, JA; Acton, G; Mehta, C; Kantarjian, HM; Stuart, RK

Published Date

  • June 1, 2015

Published In

Volume / Issue

  • 100 /

Start / End Page

  • 46 - 47

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0390-6078

Conference Name

  • 20th Congress of European-Hematology-Association

Conference Location

  • Vienna, AUSTRIA

Conference Start Date

  • June 11, 2015

Conference End Date

  • June 14, 2015